Literature DB >> 11818566

Neurotrophic factor intervention restores auditory function in deafened animals.

Takayuki Shinohara1, Göran Bredberg, Mats Ulfendahl, Ilmari Pyykkö, N Petri Olivius, Risto Kaksonen, Bo Lindström, Richard Altschuler, Josef M Miller.   

Abstract

A primary cause of deafness is damage of receptor cells in the inner ear. Clinically, it has been demonstrated that effective functionality can be provided by electrical stimulation of the auditory nerve, thus bypassing damaged receptor cells. However, subsequent to sensory cell loss there is a secondary degeneration of the afferent nerve fibers, resulting in reduced effectiveness of such cochlear prostheses. The effects of neurotrophic factors were tested in a guinea pig cochlear prosthesis model. After chemical deafening to mimic the clinical situation, the neurotrophic factors brain-derived neurotrophic factor and an analogue of ciliary neurotrophic factor were infused directly into the cochlea of the inner ear for 26 days by using an osmotic pump system. An electrode introduced into the cochlea was used to elicit auditory responses just as in patients implanted with cochlear prostheses. Intervention with brain-derived neurotrophic factor and the ciliary neurotrophic factor analogue not only increased the survival of auditory spiral ganglion neurons, but significantly enhanced the functional responsiveness of the auditory system as measured by using electrically evoked auditory brainstem responses. This demonstration that neurotrophin intervention enhances threshold sensitivity within the auditory system will have great clinical importance for the treatment of deaf patients with cochlear prostheses. The findings have direct implications for the enhancement of responsiveness in deafferented peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818566      PMCID: PMC122246          DOI: 10.1073/pnas.032677999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Evaluation of eighth nerve integrity by the electrically evoked middle latency response.

Authors:  R W Jyung; J M Miller; S C Cannon
Journal:  Otolaryngol Head Neck Surg       Date:  1989-12       Impact factor: 3.497

2.  Speech perception results for children implanted with the CLARION cochlear implant at the Medical University of Hannover.

Authors:  A Illg; S von der Haar-Heise; J E Goldring; A Lesinski-Schiedat; R D Battmer; T Lenarz
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1999-04

Review 3.  Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples.

Authors:  M P Mattson; K Furukawa
Journal:  Perspect Dev Neurobiol       Date:  1998

4.  Multivariate predictors of audiological success with multichannel cochlear implants.

Authors:  B J Gantz; G G Woodworth; J F Knutson; P J Abbas; R S Tyler
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-12       Impact factor: 1.547

5.  Estimating eighth nerve survival by electrical stimulation.

Authors:  L Smith; F B Simmons
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Jan-Feb       Impact factor: 1.547

6.  Osmotic pump implant for chronic infusion of drugs into the inner ear.

Authors:  J N Brown; J M Miller; R A Altschuler; A L Nuttall
Journal:  Hear Res       Date:  1993-11       Impact factor: 3.208

7.  Cochlear pathology of long term neomycin induced deafness in cats.

Authors:  P A Leake; G T Hradek
Journal:  Hear Res       Date:  1988-04       Impact factor: 3.208

8.  Estimation of surviving spiral ganglion cells in the deaf rat using the electrically evoked auditory brainstem response.

Authors:  R D Hall
Journal:  Hear Res       Date:  1990-11       Impact factor: 3.208

9.  Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation.

Authors:  J B Nadol; Y S Young; R J Glynn
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-06       Impact factor: 1.547

10.  Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation.

Authors:  J Otte; H F Schunknecht; A G Kerr
Journal:  Laryngoscope       Date:  1978-08       Impact factor: 3.325

View more
  58 in total

1.  Effects of antioxidants on auditory nerve function and survival in deafened guinea pigs.

Authors:  Jun Maruyama; Takahiko Yamagata; Mats Ulfendahl; Göran Bredberg; Richard A Altschuler; Josef M Miller
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

2.  Impact of sound exposure and aging on brain-derived neurotrophic factor and tyrosine kinase B receptors levels in dorsal cochlear nucleus 80 days following sound exposure.

Authors:  H Wang; T J Brozoski; L Ling; L F Hughes; D M Caspary
Journal:  Neuroscience       Date:  2010-10-27       Impact factor: 3.590

3.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

5.  Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat.

Authors:  Tiffany L Kent; Inna V Glybina; Gary W Abrams; Raymond Iezzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

6.  Development of a microfluidics-based intracochlear drug delivery device.

Authors:  William F Sewell; Jeffrey T Borenstein; Zhiqiang Chen; Jason Fiering; Ophir Handzel; Maria Holmboe; Ernest S Kim; Sharon G Kujawa; Michael J McKenna; Mark M Mescher; Brian Murphy; Erin E Leary Swan; Marcello Peppi; Sarah Tao
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

7.  Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling.

Authors:  Justin Tan; Robert K Shepherd
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.

Authors:  Rachael T Richardson; Andrew K Wise; Brianna C Thompson; Brianna O Flynn; Patrick J Atkinson; Nicole J Fretwell; James B Fallon; Gordon G Wallace; Rob K Shepherd; Graeme M Clark; Stephen J O'Leary
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

9.  Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness.

Authors:  Jun Maruyama; Josef M Miller; Mats Ulfendahl
Journal:  Neurobiol Dis       Date:  2007-08-11       Impact factor: 5.996

Review 10.  Trends in cochlear implants.

Authors:  Fan-Gang Zeng
Journal:  Trends Amplif       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.